世界の月経前不快気分障害（PMDD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Premenstrual Dysphoric Disorder (PMDD) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4754 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、月経前不快気分障害（PMDD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注入剤、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・月経前不快気分障害（PMDD）の市場動向 ・企業の競争状況、市場シェア ・月経前不快気分障害（PMDD）の種類別市場規模と予測2016-2027（錠剤、注入剤、その他） ・月経前不快気分障害（PMDD）の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・月経前不快気分障害（PMDD）の北米市場規模2016-2027（アメリカ、カナダ） ・月経前不快気分障害（PMDD）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・月経前不快気分障害（PMDD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・月経前不快気分障害（PMDD）の中南米市場規模2016-2027（メキシコ、ブラジル） ・月経前不快気分障害（PMDD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Teva、Eli Liliy、Pfizer、Bayer、GSK、Apotex、Bristol Laboratories、Mylan、Allergan） ・結論

Premenstrual dysphoric disorder (PMDD) is a health problem that is similar to premenstrual syndrome (PMS) but is more serious. PMDD causes severe irritability, depression, or anxiety in the week or two before your period starts. Symptoms usually go away two to three days after your period starts.

Market Analysis and Insights: Global Premenstrual Dysphoric Disorder (PMDD) Market
The global Premenstrual Dysphoric Disorder (PMDD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Premenstrual Dysphoric Disorder (PMDD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Premenstrual Dysphoric Disorder (PMDD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Premenstrual Dysphoric Disorder (PMDD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Premenstrual Dysphoric Disorder (PMDD) market.

Global Premenstrual Dysphoric Disorder (PMDD) Scope and Market Size
Premenstrual Dysphoric Disorder (PMDD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Premenstrual Dysphoric Disorder (PMDD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Table Product
Inject Product
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Eli Liliy
Pfizer
Bayer
GSK
Apotex
Bristol Laboratories
Mylan
Allergan

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Table Product
1.2.3 Inject Product
1.2.4 Others
1.3 Market by Application
1.3.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Perspective (2016-2027)
2.2 Premenstrual Dysphoric Disorder (PMDD) Growth Trends by Regions
2.2.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Premenstrual Dysphoric Disorder (PMDD) Historic Market Share by Regions (2016-2021)
2.2.3 Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Regions (2022-2027)
2.3 Premenstrual Dysphoric Disorder (PMDD) Industry Dynamic
2.3.1 Premenstrual Dysphoric Disorder (PMDD) Market Trends
2.3.2 Premenstrual Dysphoric Disorder (PMDD) Market Drivers
2.3.3 Premenstrual Dysphoric Disorder (PMDD) Market Challenges
2.3.4 Premenstrual Dysphoric Disorder (PMDD) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue
3.1.1 Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Revenue (2016-2021)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Players (2016-2021)
3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Premenstrual Dysphoric Disorder (PMDD) Revenue
3.4 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio
3.4.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2020
3.5 Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Area Served
3.6 Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service
3.7 Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Type
4.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Type (2016-2021)
4.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2022-2027)

5 Premenstrual Dysphoric Disorder (PMDD) Breakdown Data by Application
5.1 Global Premenstrual Dysphoric Disorder (PMDD) Historic Market Size by Application (2016-2021)
5.2 Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
6.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
6.2.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
6.2.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
6.2.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
6.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
6.3.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
6.3.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
6.3.3 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
6.4 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
6.4.1 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
6.4.2 North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
7.2.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
7.2.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
7.2.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
7.3.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
7.3.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
7.3.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
7.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
7.4.1 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
7.4.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
8.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
8.2.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
8.3.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region
8.4.1 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
9.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
9.2.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
9.2.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
9.2.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
9.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
9.3.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
9.3.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
9.3.3 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
9.4 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
9.4.1 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
9.4.2 Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size (2016-2027)
10.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
10.2.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
10.3.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country
10.4.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Introduction
11.1.4 Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Eli Liliy
11.2.1 Eli Liliy Company Details
11.2.2 Eli Liliy Business Overview
11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Introduction
11.2.4 Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.2.5 Eli Liliy Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Introduction
11.3.4 Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Introduction
11.4.4 Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Introduction
11.5.4 GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.5.5 GSK Recent Development
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Apotex Business Overview
11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Introduction
11.6.4 Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.6.5 Apotex Recent Development
11.7 Bristol Laboratories
11.7.1 Bristol Laboratories Company Details
11.7.2 Bristol Laboratories Business Overview
11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Introduction
11.7.4 Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.7.5 Bristol Laboratories Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Introduction
11.8.4 Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Introduction
11.9.4 Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
11.9.5 Allergan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Table Product
Table 3. Key Players of Inject Product
Table 4. Key Players of Others
Table 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2016-2021)
Table 9. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2022-2027)
Table 11. Premenstrual Dysphoric Disorder (PMDD) Market Trends
Table 12. Premenstrual Dysphoric Disorder (PMDD) Market Drivers
Table 13. Premenstrual Dysphoric Disorder (PMDD) Market Challenges
Table 14. Premenstrual Dysphoric Disorder (PMDD) Market Restraints
Table 15. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players (2016-2021)
Table 17. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2020)
Table 18. Ranking of Global Top Premenstrual Dysphoric Disorder (PMDD) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Premenstrual Dysphoric Disorder (PMDD) Product Solution and Service
Table 22. Date of Enter into Premenstrual Dysphoric Disorder (PMDD) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2016-2021)
Table 26. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application (2016-2021)
Table 30. Global Premenstrual Dysphoric Disorder (PMDD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva Premenstrual Dysphoric Disorder (PMDD) Product
Table 65. Teva Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 66. Teva Recent Development
Table 67. Eli Liliy Company Details
Table 68. Eli Liliy Business Overview
Table 69. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product
Table 70. Eli Liliy Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 71. Eli Liliy Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product
Table 75. Pfizer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Premenstrual Dysphoric Disorder (PMDD) Product
Table 80. Bayer Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. GSK Company Details
Table 83. GSK Business Overview
Table 84. GSK Premenstrual Dysphoric Disorder (PMDD) Product
Table 85. GSK Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 86. GSK Recent Development
Table 87. Apotex Company Details
Table 88. Apotex Business Overview
Table 89. Apotex Premenstrual Dysphoric Disorder (PMDD) Product
Table 90. Apotex Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 91. Apotex Recent Development
Table 92. Bristol Laboratories Company Details
Table 93. Bristol Laboratories Business Overview
Table 94. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product
Table 95. Bristol Laboratories Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 96. Bristol Laboratories Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Allergan Company Details
Table 102. Allergan Business Overview
Table 103. Allergan Premenstrual Dysphoric Disorder (PMDD) Product
Table 104. Allergan Revenue in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021) & (US$ Million)
Table 105. Allergan Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Type: 2020 VS 2027
Figure 2. Table Product Features
Figure 3. Inject Product Features
Figure 4. Others Features
Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Premenstrual Dysphoric Disorder (PMDD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions: 2020 VS 2027
Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Regions (2022-2027)
Figure 14. Global Premenstrual Dysphoric Disorder (PMDD) Market Share by Players in 2020
Figure 15. Global Top Premenstrual Dysphoric Disorder (PMDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Premenstrual Dysphoric Disorder (PMDD) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Premenstrual Dysphoric Disorder (PMDD) Revenue in 2020
Figure 17. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2016-2021)
Figure 18. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Type (2022-2027)
Figure 19. North America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
Figure 21. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
Figure 22. North America Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
Figure 23. United States Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
Figure 27. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
Figure 28. Europe Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
Figure 29. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Premenstrual Dysphoric Disorder (PMDD) Market Share by Region (2016-2027)
Figure 39. China Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
Figure 47. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
Figure 48. Latin America Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
Figure 49. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Share by Country (2016-2027)
Figure 55. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Premenstrual Dysphoric Disorder (PMDD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Teva Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 59. Eli Liliy Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 63. Apotex Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 64. Bristol Laboratories Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 66. Allergan Revenue Growth Rate in Premenstrual Dysphoric Disorder (PMDD) Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---